Phase I research hub

A two-part, open-label study to assess the pharmacokinetics, pharmacodynamics and safety of single doses of inhaled and intravenously administered D,L lysine acetylsalicylate • glycine (LASAG) in healthy adult subjects: Study Part A follows a randomized, cross-over design to compare three dose levels of inhaled LASAG to one dose level of intravenously administered LASAG and Study Part B follows a single group design to investigate a XXXXX LASAG inhalation solution.

This early-stage study is looking at a new way to give a migraine medicine, either as an inhaled spray or through a drip. It's for healthy adults to see how the medicine works in the body and if it's safe.